Karuna Therapeutics (KRTX) executive Brannan sold 5,000 shares for $889K at an average $177.85 under a 10b5-1 plan
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Stephen K. Brannan (executive at Karuna Therapeutics Inc., KRTX) reported that they sold 5,000 shares for $889K at an average $177.85, and acquired 7,500 shares at an average $89.58 on Nov 8, 2023. After these transactions the filing shows 33,650 shares held directly.
- Reporting person
- Brannan Stephen K.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 8, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +7,500 | avg $89.58 | $672K | 38,650 direct |
| Nov 8, 2023 | Open-market sale (S) | Common Stock1, 2, 3, ... | -5,000 | avg $177.85 | $889K | 33,650 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 8, 2023 | Exercise or conversion of a derivative (M) | Option (right to buy)On 7,500 Common Stock1, 7, 8 | -7,500 | - | - | 31,350 direct |
Holdings before and after
- Common Stock: 31,150 to 33,650 direct
- Option (right to buy): 17,177 to 31,350 direct
Footnotes from the filing
- 1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2023.
- 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.53 to $174.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (6) to this Form 4.
- 3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.58 to $175.80, inclusive.
- 7. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter.
- 8. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of February 23, 2021, with additional vesting as to 6.25% of the shares underlying the option award at the end of each three month period thereafter.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Brannan report in this KRTX Form 4?
Stephen K. Brannan (executive at Karuna Therapeutics Inc., KRTX) reported that they sold 5,000 shares for $889K at an average $177.85, and acquired 7,500 shares at an average $89.58 on Nov 8, 2023. After these transactions the filing shows 33,650 shares held directly.
How many KRTX shares does Brannan hold after this filing?
The filing shows 33,650 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this KRTX insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for KRTX
Earlier insider filings at KRTX
- Oct 10, 2023Brannan Stephen K. exercised 7,500 shares at a strike of $89.58 and sold $866,213 worth of shares (5,000 units at $173.24), increasing direct ownership by 9% to 31,150 units (SEC Form 4)
- Oct 3, 2023Brown Jason Parker was granted 4,496 shares, increasing direct ownership by 27% to 21,445 units (SEC Form 4)
- Sep 11, 2023SEC Form 4: Brannan Stephen K. exercised 7,500 shares at a strike of $89.58 and sold $920,203 worth of shares (5,000 units at $184.04), increasing direct ownership by 10% to 28,650 units
- Sep 5, 2023SEC Form 4: Jonas Jeffrey M exercised 13,809 shares at a strike of $7.27 and sold $2,595,104 worth of shares (13,809 units at $187.93)
- Aug 24, 2023SEC Form 4: Ignelzi Troy A. exercised 1,500 shares at a strike of $9.20 and sold $262,683 worth of shares (1,500 units at $175.12)
Keep researching KRTX
- KRTX insider tradesEvery buy and sale reported by Karuna Therapeutics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
KRTX
Karuna Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2019
Get push alerts for KRTX
Full KRTX profile on Quantisnow Follow KRTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time